Variant report
Variant | nsv968545 |
---|---|
Chromosome Location | chr8:49990010-49993737 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:49990025..49992623-chr8:49996686..49998822,3 | K562 | blood: | |
2 | chr8:49991750..49994604-chr8:49995400..49997837,2 | K562 | blood: | |
3 | chr8:49986949..49989384-chr8:49993295..49995590,2 | K562 | blood: | |
4 | chr8:49977011..49978877-chr8:49988078..49990673,2 | K562 | blood: | |
5 | chr8:49990906..49993749-chr8:49994694..49997206,2 | MCF-7 | breast: | |
6 | chr8:49984428..49986126-chr8:49991060..49993581,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000168333 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191680382 | chr8:49990063-49990064 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs4873311 | chr8:49990075-49990076 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs78652735 | chr8:49990090-49990091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571696110 | chr8:49990129-49990130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142855924 | chr8:49990150-49990151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs4873095 | chr8:49990166-49990167 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs552387261 | chr8:49990213-49990214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs570560620 | chr8:49990236-49990237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540468501 | chr8:49990285-49990286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150647879 | chr8:49990387-49990388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183892074 | chr8:49990394-49990395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs16939396 | chr8:49990405-49990406 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs188219822 | chr8:49990460-49990461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10577045 | chr8:49990472-49990473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs398067790 | chr8:49990475-49990476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs553467488 | chr8:49990481-49990482 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572151941 | chr8:49990485-49990486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182085351 | chr8:49990503-49990504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545435407 | chr8:49990530-49990531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564162646 | chr8:49990537-49990538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576584732 | chr8:49990542-49990543 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11442530 | chr8:49990544-49990545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs5891292 | chr8:49990545-49990546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397947606 | chr8:49990546-49990547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs341803 | chr8:49990578-49990579 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs552328519 | chr8:49990608-49990609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185702318 | chr8:49990659-49990660 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190225919 | chr8:49990744-49990745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs16939398 | chr8:49990749-49990750 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs559480713 | chr8:49990769-49990770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563595755 | chr8:49990777-49990778 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370570084 | chr8:49990783-49990784 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570830317 | chr8:49990785-49990786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533315343 | chr8:49990825-49990826 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551583760 | chr8:49990837-49990838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs142989172 | chr8:49990854-49990855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs182053348 | chr8:49990891-49990892 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574010431 | chr8:49990971-49990972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531552188 | chr8:49990993-49990994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs112607909 | chr8:49991006-49991007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568392764 | chr8:49991033-49991034 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139863853 | chr8:49991034-49991035 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553994385 | chr8:49991056-49991057 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs375027492 | chr8:49991061-49991062 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs78244324 | chr8:49991074-49991075 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs539392280 | chr8:49991081-49991082 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs557584341 | chr8:49991096-49991097 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs76895399 | chr8:49991118-49991119 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs367693711 | chr8:49991133-49991134 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs555541252 | chr8:49991134-49991135 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22014070 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:49984600-49991400 | Weak transcription | K562 | blood |
2 | chr8:49987200-49998800 | Weak transcription | Psoas Muscle | Psoas |
3 | chr8:49989000-49990800 | Weak transcription | Gastric | stomach |
4 | chr8:49989000-49990800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
5 | chr8:49990400-49992000 | Enhancers | Stomach Mucosa | stomach |
6 | chr8:49990800-49991000 | Enhancers | Gastric | stomach |
7 | chr8:49990800-49991600 | Enhancers | Skeletal Muscle Female | skeletal muscle |
8 | chr8:49991000-49991400 | Weak transcription | Gastric | stomach |
9 | chr8:49991000-49991800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr8:49991400-49991600 | Enhancers | K562 | blood |
11 | chr8:49991400-49991800 | Enhancers | Gastric | stomach |
12 | chr8:49991400-49992000 | Enhancers | Fetal Intestine Large | intestine |
13 | chr8:49991600-49994200 | Weak transcription | K562 | blood |
14 | chr8:49991600-49994600 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
15 | chr8:49992000-49994800 | Weak transcription | Stomach Mucosa | stomach |